Answers are grounded in this paper and cite their sources.
Population-based study demonstrates the impact of co-occurrence measures on multimorbidity network analyses, suggesting sensitivity analyses are necessary.
Multimorbidity network analyses are sensitive to disease co-occurrence measurement. Co-occurrence measures should be selected considering their intrinsic properties, research objectives, and the health condition prevalence relationships of greatest interest. Researchers should consider conducting sensitivity analyses using different co-occurrence measures.
No takes yet. Share an insight, caveat, or question.
Monchka et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: